Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
FMED vs GDOC
Shared holdings
19
FMED covered by GDOC
26.37%
GDOC covered by FMED
26.37%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
FMED (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| Fidelity Securities Lending Cash Central Fund | 11.15% | |
| DANAHER CORP | 3.77% | |
| UCB SA | 3.61% | |
| BOSTON SCIENTIFIC CORP | 3.58% | |
| ARGENX SE SPONSORED ADR | 3.41% | |
| COGENT BIOSCIENCES INC | 3.40% | |
| ALNYLAM PHARMACEUTICALS INC | 2.94% | |
| INTUITIVE SURGICAL INC | 2.79% | |
| VEEVA SYSTEMS-A | 2.65% | |
| INSULET CORP | 2.29% | |
| MODERNA INC | 2.28% | |
| WAYSTAR HOLDING CORP | 2.24% | |
| EDWARDS LIFESCIENCES CORP | 2.20% | |
| LIFESTANCE HEALTH GROUP INC | 2.18% | |
| VAXCYTE INC | 2.03% | |
| INSMED INC | 1.74% | |
| Sartorius Stedim Biotech S.A. | 1.74% | |
| STRYKER CORP | 1.65% | |
| LILLY ELI and CO | 1.58% | |
| PRIVIA HEALTH GROUP INC | 1.56% | |
| THERMO FISHER SCIENTIFIC INC | 1.55% | |
| LEGEND BIOTECH CORP SPON ADR | 1.53% | |
| 10X GENOMICS INC | 1.51% | |
| PENUMBRA INC | 1.51% | |
| KYMERA THERAPEUTICS INC | 1.33% | |
| STOKE THERAPEUTICS INC | 1.33% | |
| Ascendis Pharma A/S | 1.32% | |
| UNITEDHEALTH GRP | 1.27% | |
| NATERA INC | 1.27% | |
| LONZA GROUP -REG | 1.26% | |
| CYTOKINETICS INC | 1.20% | |
| CARIS LIFE SCIENCES INC | 1.17% | |
| CRINETICS PHARMACEUTICALS INC | 1.14% | |
| DEXCOM INC | 1.12% | |
| DISC MEDICINE INC | 1.08% | |
| VERACYTE INC | 1.07% | |
| RESMED INC | 1.05% | |
| XENON PHARMACEUTICALS INC | 0.99% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 0.89% | |
| NUVALENT INC-A | 0.89% | |
| CYTOMX THERAPEUTICS INC | 0.88% | |
| ALIGNMENT HEALTHCARE INC | 0.84% | |
| ALIGN TECHNOLOGY INC | 0.83% | |
| GUARDANT HEALTH INC | 0.82% | |
| WAVE LIFE SCIENCES LTD | 0.81% | |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 0.78% | |
| ROIVANT SCIENCES LTD | 0.76% | |
| REPLIGEN CORP | 0.74% | |
| ENLIVEN THERAPEUTICS INC | 0.74% | |
| BIO-TECHNE CORP | 0.72% |
GDOC (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 12.20% | |
| JOHNSON&JOHNSON | 8.10% | |
| ASTRAZENECA PLC | 6.41% | |
| MERCK & CO | 5.99% | |
| BOSTON SCIENTIFIC CORP | 5.81% | |
| THERMO FISHER SCIENTIFIC INC | 4.62% | |
| INTUITIVE SURGICAL INC | 4.47% | |
| GUARDANT HEALTH INC | 3.73% | |
| HOYA CORP | 3.63% | |
| ARGENX SE SPONSORED ADR | 3.60% | |
| CENCORA INC | 3.39% | |
| ABBOTT LABS | 3.13% | |
| LONZA GROUP -REG | 2.94% | |
| AGILENT TECHNOLOGIES INC | 2.91% | |
| DEXCOM INC | 2.68% | |
| ROIVANT SCIENCES LTD | 2.23% | |
| METTLER-TOLEDO INTL INC | 1.77% | |
| APOGEE THERAPEUTICS INC | 1.62% | |
| Sartorius Stedim Biotech S.A. | 1.59% | |
| IONIS PHARMACEUTICALS INC | 1.41% | |
| QIAGEN NV | 1.39% | |
| REPLIGEN CORP | 1.26% | |
| INSMED INC | 1.22% | |
| PENUMBRA INC | 1.14% | |
| Goldman Sachs Treasury Obligations Fund Institutional Class | 1.09% | |
| NATERA INC | 1.05% | |
| XENON PHARMACEUTICALS INC | 1.03% | |
| ROYALTY PHARMA PLC | 1.01% | |
| UNITEDHEALTH GRP | 1.01% | |
| CYTOKINETICS INC | 0.98% | |
| BRIDGEBIO PHARMA INC | 0.92% | |
| MADRIGAL PHARMACEUTICALS INC | 0.89% | |
| RHYTHM PHARMACEUTICALS INC | 0.88% | |
| CG ONCOLOGY INC | 0.83% | |
| ARCELLX INC | 0.82% | |
| GENEDX HOLDINGS CORP-A | 0.59% | |
| REVOLUTION MEDICINES INC | 0.52% | |
| INSULET CORP | 0.47% | |
| ULTRAGENYX PHARMA INC | 0.37% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.30% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.